BEAM EPS Estimates
Beam Therapeutics Inc.
$24.24
-$2.78(-10.29%)
57
Overall
60
Value
63
Tech
50
Quality
Market Cap
$2.51B
Volume
1.71M
52W Range
$20.23 - $38.26
Target Price
$45.75
BEAM EPS estimates: the consensus estimate for Beam Therapeutics Inc.'s current fiscal year is -$4.66 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BEAM EPS Estimates
- EPS estimate, current quarter
- $-1.29
- EPS estimate, next quarter
- $-1.32
- EPS estimate, current year
- $-4.66
- EPS estimate, next year
- $-5.14
- EPS growth, 3-year
- +41.90%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.81 |
| 2024 | $-4.58 |
| 2023 | $-1.72 |
| 2022 | $-4.13 |
| 2021 | $-5.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BEAM | $24.24 | -10.3% | 1.71M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |